Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07469384 · ClinicalTrials.gov registry record · NA
Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
A NA study of Schizoaffective Disorder and SCHIZOPHRENIA 1 (Disorder), sponsored by Nathan Kline Institute for Psychiatric Research.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07469384: Recruiting NA study of Schizoaffective Disorder and SCHIZOPHRENIA 1 (Disorder), sponsored by Nathan Kline Institute for Psychiatric Research.
NCT07469384 is a NA study of Schizoaffective Disorder and SCHIZOPHRENIA 1 (Disorder) that is actively recruiting participants, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 120 participants, below the 171-participant average among 103 other Schizoaffective Disorder trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07469384, a NA study of Schizoaffective Disorder and SCHIZOPHRENIA 1 (Disorder), is actively recruiting participants, sponsored by Nathan Kline Institute for Psychiatric Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the ability of transcranial direct current stimulation (tDCS) applied over the motion processing area of the brain (area MT) to improve face emotion recognition (FER) ability. tDCS is a type of non-invasive brain stimulation in which low level currents are applied over the scalp to influence underlying brain function. In schizophrenia, impaired ability to detect facial motion has been shown to contribute to impaired FER, which, in turn, leads to difficulties in social cognition and poor social outcome. The study will use both fMRI and EEG to measure brain function while participants view moving dot and dynamic face stimuli. Analyses will compare changes in fMRI and EEG activity in individuals receiving active vs. sham stimulation.
Primary Outcome
Magnitude of activation in area MT+ during random dot kinematogram (RDK) stimulation measured by the beta weight of the BOLD fMRI signal, expressed in units of percentage signal change
Conditions Studied
Interventions
- DEVICE Sham stimulation
- DEVICE transcranial direct current stimulation
Study Locations (1)
New York
- Nathan Kline Institute - Orangeburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2030-07 |
| Phase | NA |
What NCT07469384 shows while recruiting
NCT07469384 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 171-participant average among 103 other Schizoaffective Disorder trials with a reported enrollment target (30% lower).
The record links to 2 conditions, with Schizoaffective Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham stimulation is the first listed.
NCT07469384 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07469384 about?
NCT07469384 is a clinical study titled "Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways". This study investigates the ability of transcranial direct current stimulation (tDCS) applied over the motion processing area of the brain (area MT) to improve face emotion recognition (FER) ability. tDCS is a type of non-invasive brain stimulation in which low level currents are applied over the sc...
What is the current status of trial NCT07469384?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-02-01. Estimated completion is 2030-07.
What conditions does trial NCT07469384 study?
This clinical trial studies the following conditions: Schizoaffective Disorder, SCHIZOPHRENIA 1 (Disorder).
What interventions are being tested in trial NCT07469384?
The interventions under investigation include: Sham stimulation (DEVICE), transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT07469384?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07469384 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizoaffective Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07469384's enrollment target sits among peer trials
120 29th of 103 higher than 74 of 103 other Schizoaffective Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizoaffective Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
RECRUITING · NA
-
Effectiveness of Motivation Skills Training (MST)
RECRUITING · NA
-
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
RECRUITING · NA
-
Prebiotic Treatment in People With Schizophrenia
RECRUITING · NA
-
Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI